Stem Cell Directors Conclude Cardiovascular Session

Mar 10, 2011

∙ Paid

The briefing on cardiovascular disease for directors of the California stem cell agency has concluded. The governing board is expected to convene shortly to deal with other matters, ranging from selection of a new chair to a $125,000 program to send patient advocates to the World Stem Cell Stem Summit in Pasadena.

Keep reading with a 7-day free trial

Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.